New Report Says It’s Time for Big Pharma to ‘Play or Pay’ to Tackle Superbugs
By Andrea Germanos A new plan for tackling the growing threat of antibiotic-resistant microbes, or so-called superbugs, addresses the unnecessary use of antibiotics and includes a call on Big Pharma to “play or pay” to help bring successful treatments to the market. The report, commissioned by…

